Spyre Therapeutics, Inc. (SYRE)
(Delayed Data from NSDQ)
$34.89 USD
+1.33 (3.96%)
Updated Apr 29, 2024 04:00 PM ET
After-Market: $34.88 -0.01 (-0.03%) 7:58 PM ET
5-Strong Sell of 5 5
F Value D Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/09/2024
Time: -- |
3/2024 | $-0.90 | 0.00% |
Earnings Summary
For their last quarter, Spyre Therapeutics, Inc. (SYRE) reported earnings of -$2.28 per share, missing the Zacks Consensus Estimate of -$0.48 per share. This reflects a negative earnings surprise of 375.00%. Look out for SYRE's next earnings release expected on May 09, 2024. For the next earning release, we expect the company to report earnings of -$0.90 per share, reflecting a year-over-year increase of 82%.
Earnings History
Price & Consensus
Zacks News for SYRE
Here's Why Spyre Therapeutics (SYRE) Could be Great Choice for a Bottom Fisher
SYRE: What are Zacks experts saying now?
Zacks Private Portfolio Services